Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-091209

CONCERT PHARMACEUTICALS, INC. · CNCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Roger D Tung
Officer — Chief Executive Officer · Director
Period of report
Jan 11, 2016
Accepted (ET)
Jan 13, 2016 · 5:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJul 7, 2015G12,888$0.00A501,355D
Common StockF2Jul 7, 2015G12,888$0.00D121,873IBy Roger D. Tung 2011 GRAT
Common StockJan 11, 2016M18,000$4.58A519,355D
Common StockF3holding———13,274IBy Tung Family Investment Trust
Common StockF4holding———12,389IBy RD Tung Irrevocable Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F5$4.58Jan 11, 2016M18,000D—Dec 19, 2018Common Stock18,00035,097D

Explanation of responses